New Concepts in Rheumatic Pain

Rheumatic Disease Clinics of North America

Volumn 34, Issue 2, 2008, Pages 267-283

  Fitzcharles, Mary Ann ^a,b   Shir, Yoram ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL; CORTICOSTEROID; LOCAL ANESTHETIC AGENT; METHYLPHENIDATE; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SEROTONIN; SODIUM CHANNEL; SUBSTANCE P;

ALLODYNIA; ARTHRITIS; CHRONIC PAIN; DISEASE COURSE; DRUG MECHANISM; FATIGUE; HUMAN; HYPERALGESIA; MOOD DISORDER; MUSCULOSKELETAL PAIN; NOCICEPTIVE RECEPTOR; OSTEOARTHRITIS; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOGENESIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHEUMATIC DISEASE; SENSORY NERVE CELL; SLEEP DISORDER; TISSUE INJURY; UNSPECIFIED SIDE EFFECT;

ANALGESICS; HUMANS; NOCICEPTORS; PAIN; QUALITY OF LIFE; RHEUMATIC DISEASES;

EID: 47049112175     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2008.03.005     Document Type: Review

References (73)

1. Phillips D.M. JCAHO pain management standards are unveiled. JAMA 284 (2000) 428-429
2. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health condition among adults- United States, 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 120-125
3. The burden of musculoskeletal conditions at the start of the millennium. World Health Organ Tech Rep ser 919 (2003) 1-218
4. Cooper R.G., Booker C.K., and Spanswick C.C. What is pain management, and what is its relevance to the rheumatologist?. Rheumatology 42 (2003) 1133-1137
5. Skevington S.M. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain 76 (1998) 395-406
6. Fries J.F., Spitz P., and Young D.Y. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9 (1982) 789-793
7. Fitzcharles M.A., Almahrezi A., and Shir Y. Pain: understanding and challenges for the rheumatologist. Arthritis Rheum 52 (2005) 3685-3692
8. Hootman J.M., and Helmick C.G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 54 (2006) 226-229
9. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 (2003) 356-361
10. Krasnokutsky S., Samuels J., and Abramson S.B. Osteoarthritis in 2007. Bull NYU Hosp Jt Dis 65 (2007) 222-228
11. In: Merskey H., and Bogduk N. (Eds). Classification of chronic pain (1994), IASP Press, Seattle (WA)
12. Sprangers M.A., de Regt E.B., Andries F., et al. Which chronic conditions are associated with better or poorer quality of life?. J Clin Epidemiol 53 9 (2000) 895-907
13. Salaffi F., De Angelis R., Grassi W., et al. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The mapping study. Clin Exp Rheumatol 23 (2005) 819-828
14. Macfarlane G.J. Looking back: developments in our understanding of the occurrence, aetiology and prognosis of chronic pain 1954-2004. Rheumatology 44 Suppl 4 (2005) 23-26
15. Louw Q.A., Morris L.D., and Grimmer-Somers K. The prevalence of low back pain in Africa: a systematic review. BMC Musculoskelet Disord 8 (2007) 105
16. Helmick C.G., Felson D.T., Lawrence R.C., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States part I. Arthritis Rheum 58 (2008) 15-25
17. Kelsey J.L., and White A.A. Epidemiology and impact of low back pain. Spine 5 (1980) 133-142
18. Lawrence R.C., Felson D.T., Helmick C.G., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States part II. Arthritis Rheum 58 1 (2008) 26-35
19. Harkness E.F., Macfarlane G.J., Silman A.J., et al. Is musculoskeletal pain more common now than 40 years ago?: two population-based cross-sectional studies. Rheumatology 44 (2005) 890-895
20. Kidd B.L., and Urban L.A. Mechanisms of inflammatory pain. Br J Anaesth 87 (2001) 3-11
21. Kidd B.L. Osteoarthritis and joint pain. Pain 123 (2006) 6-9
22. Haywood L., McWilliams D.F., Pearson C.I., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48 (2003) 2173-2177
23. Raja S.N., Meyer R.A., Ringkamp M., et al. Peripheral neural mechanisms of nociception. In: Wall P.D., and Melzack R. (Eds). Textbook of pain (1999), Churchill Livingstone, London 11-57
24. Langford L.A., and Schmidt R.F. Afferent and efferent axons in the medial and posterior articular nerves of the cat. Anat Rec 206 (1983) 71-78
25. Heppelmann B., and McDougall J.J. Inhibitory effect of amiloride and gadolinium on fine afferent nerves in the rat knee: evidence of mechanogated ion channels in joints. Exp Brain Res 167 (2005) 114-118
26. McQueen D.S. Inflammatory pain and the joint. In: Brain S.D., and Moore P.K. (Eds). Pain and neurogenic inflammation (1999), Birkhauser Verlag, Basel (Switzerland) 137-166
27. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7 (1984) 309-338
28. Melzack R., and Wall P.D. Evolution of pain theories. Int Anesthesiol Clin 8 (1970) 3-34
29. Coderre T.J., Katz J., Vaccarino A.L., et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
30. Schaible H.G., Del Rosso A., and Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 3 (2005) 77-101
31. Westlund K.N., McNeill D.L., and Coggeshall R.E. Glutamate immunoreactivity in rat dorsal root axons. Neurosci Lett 96 (1989) 13-17
32. Dickenson A.H., and Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fibre stimulation. Neuropharmacology 26 (1987) 1235-1238
33. Heppenstall P.A., and Lewin G.R. Neurotrophins, nociceptors and pain. Curr Opin Anaesthesiol 13 (2000) 573-576
34. McDougall J.J. Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res Ther 8 (2006) 220-230
35. Xiao W.H., and Bennett G.J. Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition. Anesthesiology 107 (2007) 813-821
36. Bolay H., and Moskowitz M.A. Mechanisms of pain modulation in chronic syndromes. Neurology 59 (2002) S2-S7
37. Woolf C.J., Bennett G.J., Doherty M., et al. Towards a mechanism-based classification of pain?. Pain 77 (1998) 227-229
38. Finnerup N.B., Otto M., Jensen T.S., et al. An evidence-based algorithm for the treatment of neuropathic pain. MedGenMed 9 (2007) 36
39. Schett G. Joint remodelling in inflammatory disease. Ann Rheum Dis 66 Suppl 3 (2007) 42-44
40. Tak P.P., and Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43 (2000) 2619-2633
41. Felson D.T., Chaisson C.E., Hill C.L., et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 134 (2001) 541-549
42. Felson D.T., McLaughlin S., Goggins J., et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 139 (2003) 330-336
43. Findlay D.M. Vascular pathology and osteoarthritis. Rheumatology 46 (2007) 1763-1768
44. Tamai M., Kawakami A., Uetani M., et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patient with early-stage rheumatoid arthritis. J Rheumatol 34 11 (2007) 2154-2157
45. Hunter D.J., Zhang Y., Niu J., et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 54 (2006) 1529-1535
46. Garnero P., Peterfy C., Zaim S., et al. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum 52 (2005) 2822-2829
47. Zhai G., Blizzard L., Srikanth V., et al. Correlates of knee pain in older adults: Tasmanian older adult cohort study. Arthritis Rheum 55 (2006) 264-271
48. Carrino J.A., Blum J., Parellada J.A., et al. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthritis Cartilage 14 (2006) 1081-1085
49. Uutela T., Kautiainen H., and Hakala M. Nottingham health profile questionnaire incorporates important aspects of the patient perspective into outcome assessment in rheumatoid arthritis. Clin Exp Rheumatol 26 (2008) 39-44
50. Tugwell P., Wells G., Strand V., et al. Clinical improvement as reflected in measures of function and health related quality of life: sensitivity and relative efficiency to detect a treatment effect in a 12 month placebo controlled trial comparing leflunomide with methotrexate. Arthritis Rheum 43 (2000) 506-514
51. Strand V., Cohen S., Crawford B., et al. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology 43 (2004) 640-647
52. Cohen S., Strand V., Aguilar D., et al. Patient versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology 43 (2004) 648-656
53. Dhanani S., Quenneville J., Perron M., et al. Minimal difference in pain associated with change in quality of life in children with rheumatic diseases. Arthritis Care Res 47 (2002) 501-505
54. Kosinki M., Zhao S.Z., Dedhiya S., et al. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 43 (2000) 1478-1487
55. Häkkinen A., Kautiainen H., Hannonen P., et al. Muscle strength, pain, and disease activity explain individual subdimensions of the health assessment questionnaire disability index, especially in women with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 30-34
56. Leeb B.F., Haindl P.M., Maktari A., et al. Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol 34 (2007) 2382-2387
57. Leeb B.F., Andel I., Sautner J., et al. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology 43 (2004) 1504-1507
58. Scott D.L., Pugner K., Kaarela K., et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology 39 (2000) 122-132
59. Hazes J.M. Determinants of physical function in rheumatoid arthritis: association with the disease process. Rheumatology 42 Suppl 2 (2003) 17-21
60. Hutchings A., Calloway M., Choy E., et al. The longitudinal examination of arthritis pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomes. J Rheumatol 34 (2007) 2291-2300
61. Farrar J.T., Portenoy R.K., Berlin J.A., et al. Defining the clinically important difference in pain outcome measures. Pain 88 (2000) 287-294
62. Pham T., van der Heijde D., Altman R.D., et al. OMERACT-OARSI initiative: osteoarthritis research society international set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 12 (2004) 389-399
63. Guedj D., and Weinberger A. Effect of weather conditions on rheumatic patients. Ann Rheum Dis 49 (1990) 158-159
64. McAlindon T., Formica M., Schmid C.H., et al. Changes in barometric pressure and ambient temperature influence osteoarthritis pain. Am J Med 120 (2007) 429-434
65. Winfield J.B. Pain and arthritis. N C Med J 68 (2007) 444-446
66. Wolfe F., Michaud K., and Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 33 (2006) 1942-1951
67. Morin C.M., Gibson D., and Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14 (1998) 311-314
68. Cole J.C., Dubois D., and Kosinski M. Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain. Clin Ther 29 (2007) 2580-2588
69. Smith BW, Zautra AJ. The effects of anxiety and depression on weekly pain in women with arthritis. Pain, in press.
70. Boulanger A., Clark A.J., Squire P., et al. Chronic pain in Canada: have we improved our management of chronic noncancer pain?. Pain Res Manag 12 1 (2007) 39-47
71. Gardner-Nix J. Principles of opioid use in chronic noncancer pain. CMAJ 169 (2003) 38-43
72. Jovey R.D., Ennis J., Gardner-Nix J., et al. Pain society. Use of opioid analgesics for the treatment of chronic noncancer pain-a consensus statement and guidelines from the Canadian pain society, 2002. Pain Res Manag 8 Suppl A (2003) 3A-28A
73. Monsivais D., and McNeill J. Multicultural influences on pain medication attitudes and beliefs in patients with nonmalignant chronic pain syndromes. Pain Manag Nurs 8 (2007) 64-71